Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

HEALTHCARE (NY:XLV)

187.98 +0.15 (+0.08%)
Delayed Quote Updated: 12:24 PM EST, Nov 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about HEALTHCARE

< Previous 1 2 3 4 5 6 7 8 9
...
44 45 Next >
News headline image
Where These 4 Sector ETFs Stand Heading Into Year-End ↗
With earnings season winding down and the AI-driven volatility finally abating, it's time to start making some assessments that will guide your decisions into and through the year ahead. 
Via The Motley Fool
Topics Artificial Intelligence ETFs
News headline image
This ETF Has Gained 23% This Year. Is It Still Worth Buying in 2026? ↗
Defensive sectors are making a comeback in 2026. This one seems particularly well-positioned for 2027. 
Via The Motley Fool
Topics Artificial Intelligence Bonds ETFs
News headline image
Which Healthcare ETF Is the Better Buy: Fidelity’s FHLC or State Street’s XLV? ↗
XLV concentrates on 61 large-cap S&P 500 names, while FHLC casts a wider net with 365 holdings across mid and small caps. Both charge 0.08% annually. 
Via The Motley Fool
Topics ETFs Stocks
Stock Market Today: Defensive Rally Lifts the Dow 1% as Netflix Slips After Hours and Musk Puts a SpaceX-Tesla Merger on the Table ↗
Via Chartmill
Topics Stocks
News headline image
What a Mixed Midterm Result Could Mean for These 2 Health Care ETFs ↗
Polls suggest a divided government after the midterms, a scenario that historically benefits healthcare stocks. Here's how the XLV and IHF ETFs compare for investors eyeing the sector. 
Via MarketBeat
Topics ETFs
News headline image
If a Stock Market Crash Is Coming, History Says These 3 ETFs Are the Smartest Buys ↗
These funds can help you weather any storm that might be on the way. 
Via The Motley Fool
Topics ETFs Stocks
News headline image
XLV vs IBB: How Healthcare Diversification Compares to Biotech Concentration ↗
XLV offers exposure to the broader healthcare sector, while IBB targets biotech innovators. Here's how the two stack up on risk, returns, and diversification. 
Via The Motley Fool
Topics ETFs
News headline image
XLV vs. PJP: How Broad Healthcare Diversification Stacks Up to Pharma Stocks ↗
XLV's broader diversification and lower fees appeal to cost-conscious investors, while PJP's concentrated pharma bet has outperformed over the past year. 
Via The Motley Fool
Topics ETFs
News headline image
State Street XLV vs. iShares IXJ: Here's How These Healthcare ETFs Stack Up for Investors ↗
XLV's 0.08% expense ratio and 22.7% 1-year return outpace IXJ's global reach, but international diversification comes at a cost. 
Via The Motley Fool
Topics ETFs
News headline image
If the Fed Hikes Interest Rates This Month, History Says This Is the Smartest ETF to Buy Right Now ↗
If interest rates rise, writing a prescription today for the State Street Health Care Select Sector SPDR ETF is a smart idea. 
Via The Motley Fool
Topics ETFs Economy Regulatory Compliance
News headline image
Leading And Lagging Sectors For September 2, 2026 ↗
Gainers Symbol Name Price Change ($) Change (%) Volume (NYSE:XLV) State Street Health Care Select Sector SPDR ETF 172.44 0.77 0.44 12.0K (NYSE:XLB) State Street Materials Select Sector SPDR 
Via Benzinga
Topics ETFs
News headline image
Leading And Lagging Sectors For September 1, 2026 ↗
Gainers Symbol Name Price Change ($) Change (%) Volume (NYSE:XLE) State Street Energy Select Sector SPDR ETF 64.874 0.914 1.42 377.8K (NYSE:XLV) State Street Health Care Select Sector SPDR 
Via Benzinga
Topics ETFs
News headline image
Leading And Lagging Sectors For August 28, 2026 ↗
Gainers Symbol Name Price Change ($) Change (%) Volume (NYSE:XLP) State Street Consumer Staples Select Sector SPDR ETF 85.480 0.400 0.47 18.7K (NYSE:XLV) State Street Health Care Select Sector SPDR 
Via Benzinga
Topics ETFs
News headline image
Leading And Lagging Sectors For August 19, 2026 ↗
Gainers Symbol Name Price Change ($) Change (%) Volume (NYSE:XLV) State Street Health Care Select Sector SPDR ETF 172.5682 2.838 1.67 61.5K (NYSE:XLB) State Street Materials Select Sector SPDR 
Via Benzinga
Topics ETFs
News headline image
Leading And Lagging Sectors For August 10, 2026 ↗
Gainers Symbol Name Price Change ($) Change (%) Volume (NYSE:XLE) State Street Energy Select Sector SPDR ETF 58.06 0.56 0.97 91.3K (NYSE:XLV) State Street Health Care Select Sector SPDR 
Via Benzinga
Topics ETFs
News headline image
Vanguard Health Care ETF vs State Street XLV: Which ETF Is the Better Buy for Investors in 2026? ↗
XLV's concentrated 60-stock portfolio beat VHT's broader 423 holdings over five years, though VHT delivered stronger 1-year returns. 
Via The Motley Fool
Topics ETFs Economy
News headline image
State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026? ↗
XLV's lower costs and broader holdings delivered 30% more growth over five years, while BBH's concentrated biotech focus offers higher single-stock upside. 
Via The Motley Fool
Topics ETFs
News headline image
Leading And Lagging Sectors For August 5, 2026 ↗
Gainers Symbol Name Price Change ($) Change (%) Volume (NYSE:XLB) State Street Materials Select Sector SPDR ETF 52.6697 0.670 1.28 14.5K (NYSE:XLV) State Street Health Care Select Sector SPDR 
Via Benzinga
Topics ETFs
News headline image
Which Is the Better State Street Healthcare ETF: The Broad XLV or the Biotech XBI? ↗
XBI surged 76% in one year but carries triple the expense ratio and far steeper downside risk. Which fund matches your risk appetite? 
Via The Motley Fool
Topics ETFs
News headline image
XLV vs. IBBQ: Is Broad Healthcare Exposure or Biotech Growth the Better ETF Buy? ↗
IBBQ posted the stronger return over the past year, but has also experienced much higher historical volatility than XLV. 
Via The Motley Fool
Topics ETFs Intellectual Property
News headline image
XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist? ↗
PBE surged 41% in one year but endured a 35% drawdown, while XLV's diversified approach delivered steadier gains with half the volatility. 
Via The Motley Fool
Topics ETFs
News headline image
XLV vs. IHE: Which Healthcare ETF Is the Better Buy? ↗
IHE's pharma-focused portfolio delivered higher returns over the past year, while XLV offers a broader healthcare focus with a much lower expense ratio. 
Via The Motley Fool
Topics ETFs Intellectual Property
News headline image
State Street vs. First Trust: Is a Broad Healthcare or Biotech Focus Better for Your Portfolio? ↗
FBT delivered 48.5% returns over one year but carries a 0.55% expense ratio and experiences greater volatility. XLV offers lower costs, with an 0.08% expense ratio, as well as broader diversification... 
Via The Motley Fool
Topics ETFs
News headline image
Leading And Lagging Sectors For July 28, 2026 ↗
Gainers Symbol Name Price Change ($) Change (%) Volume (NYSE:XLP) State Street Consumer Staples Select Sector SPDR ETF 86.9200 1.560 1.82 50.6K (NYSE:XLV) State Street Health Care Select Sector SPDR 
Via Benzinga
Topics ETFs
News headline image
XLV vs IYH: Which Healthcare ETF Wins on Cost and Yield? ↗
State Street's fund charges just 0.08% annually versus 0.38% for iShares, but the broader portfolio offers 100 holdings versus 60. 
Via The Motley Fool
Topics ETFs
News headline image
XLV vs FHLC: Which Healthcare ETF Fits Your Portfolio? ↗
State Street's concentrated 60-stock approach outpaced Fidelity's broader 365-holding fund over five years, though both charge identical 0.08% fees. 
Via The Motley Fool
Topics ETFs
News headline image
PINK vs. XLV: How Do These Two Health Care ETFs Match Up? ↗
PINK outperformed XLV by 8.7 percentage points over one year, but carries higher fees and volatility. XLV offers lower costs and a higher dividend yield for passive healthcare exposure. 
Via The Motley Fool
Topics ETFs
News headline image
Is the VanEck Pharmaceutical ETF or State Street Health Care ETF the Better Buy for Your Portfolio? ↗
PPH targets drugmakers exclusively with higher returns but steeper costs, while XLV diversifies across medical equipment and providers at a fraction of the fee. 
Via The Motley Fool
Topics ETFs
News headline image
Leading And Lagging Sectors For July 23, 2026 ↗
Gainers Symbol Name Price Change ($) Change (%) Volume (NYSE:XLE) State Street Energy Select Sector SPDR ETF 60.25 1.05 1.77 416.2K (NYSE:XLV) State Street Health Care Select Sector SPDR 
Via Benzinga
Topics ETFs
News headline image
Which Is the Better Healthcare ETF, First Trust's Biotech-Focused FBT or State Street's Broader XLV? ↗
FBT delivered 52.4% returns over one year but with deeper drawdowns, while XLV's diversified approach offers lower costs and steadier performance. 
Via The Motley Fool
Topics ETFs
< Previous 1 2 3 4 5 6 7 8 9
...
44 45 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.